Studies have shown that bacterial endotoxin adds to the development and progression of MASLD in both humans and rodents by activating TLR4-depending signaling cascades in the liver [43,46,47]. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.